Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 0

The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.

From Leaky Gut to a Vulnerable Brain: Obesity-Associated Gut Barrier Failure in Colorectal Cancer and Cognitive Dysfunction

Lee, Soo Young, Cho, Sang Hee, Song, Juhyun·2026·Nutrients

Abstract

Obesity is a major risk factor for colorectal cancer (CRC) and is increasingly recognized as a contributor to cancer-related cognitive impairment; however, the mechanistic pathways linking metabolic dysfunction, tumor progression, and brain dysfunction remain incompletely defined. Emerging evidence indicates that obesity-induced gut microbial dysbiosis and intestinal barrier disruption may serve as a biologically plausible mechanism connecting these processes via the gut–brain axis although direct clinical causality remains to be firmly established. In obesity, alterations in gut microbiota composition characterized by depletion of barrier-protective taxa and enrichment of pro-inflammatory and genotoxic pathobionts compromise epithelial tight-junction integrity and promote metabolic endotoxemia. The translocation of microbial products, including lipopolysaccharide, sustains chronic systemic inflammation, accelerates CRC progression, and remodels the tumor microenvironment. Notably, these peripheral inflammatory signals extend beyond the intestine and tumor, disrupting blood–brain barrier integrity, activating microglia and astrocytes, and impairing synaptic plasticity within hippocampal and frontal networks. Clinically, these processes manifest as cancer-related cognitive impairment (CRCI), with predominant deficits in attention, processing speed, and working memory, which are often detectable around the time of diagnosis and independent of chemotherapy exposure. This review synthesizes in vivo, in vitro, and human evidence into a proposed theoretical “two-barrier failure” model of obesity-associated CRC and cognitive dysfunction. In addition to mechanistic synthesis, we discuss barrier-centered therapeutic strategies, including targeted probiotics, postbiotics, SCFA supplementation, obesity management through dietary and weight-loss interventions, and potential pharmacological approaches to epithelial and neurovascular barrier protection. We also outline testable clinical trial designs for evaluating these interventions in obesity-associated CRC.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3390/nu18121909

Cites

6 of 6 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 6 references

Research works printed but not linked: 88

  1. Ye, P., Xi, Y., Huang, Z., and Xu, P. (2020). Linking Obesity with Colorectal Cancer: Epidemiology and Mechanistic Insights. Cancers, 12. · DOI
  2. Gonzalez-Gutierrez, L., Motino, O., Barriuso, D., de la Puente-Aldea, J., Alvarez-Frutos, L., Kroemer, G., Palacios-Ramirez, R., and Senovilla, L. (2024). Obesity-Associated Colorectal Cancer. Int. J. Mol. Sci., 25. · DOI
  3. Quail, 2019, The obese adipose tissue microenvironment in cancer development and progression, Nat. Rev. Endocrinol., 15, 139, 10.1038/s41574-018-0126-x · DOI · Paper page
  4. Xu, Y.X.Z., and Mishra, S. (2018). Obesity-Linked Cancers: Current Knowledge, Challenges and Limitations in Mechanistic Studies and Rodent Models. Cancers, 10. · DOI
  5. NCD Risk Factor Collaboration (2016). Trends in adult body-mass index in 200 countries from 1975 to 2014: A pooled analysis of 1698 population-based measurement studies with 19.2 million participants. Lancet, 387, 1377–1396. · DOI · Paper page
  6. Scoccianti, 2016, Body Fatness and Cancer—Viewpoint of the IARC Working Group, N. Engl. J. Med., 375, 794, 10.1056/NEJMsr1606602 · DOI · Paper page
  7. Cani, 2007, Metabolic endotoxemia initiates obesity and insulin resistance, Diabetes, 56, 1761, 10.2337/db06-1491 · DOI · Paper page
  8. Iyengar, 2016, Obesity and Cancer Mechanisms: Tumor Microenvironment and Inflammation, J. Clin. Oncol., 34, 4270, 10.1200/JCO.2016.67.4283 · DOI · Paper page
  9. Nguyen, J.C., Killcross, A.S., and Jenkins, T.A. (2014). Obesity and cognitive decline: Role of inflammation and vascular changes. Front. Neurosci., 8. · DOI
  10. Vardy, 2014, Cognitive function and fatigue after diagnosis of colorectal cancer, Ann. Oncol., 25, 2404, 10.1093/annonc/mdu448 · DOI
  11. Nguyen, 2025, Regional hyperconnectivity in the medial temporal lobes as a maladaptive mechanism for colorectal cancer-related cognitive decline, Sci. Rep., 15, 29954, 10.1038/s41598-025-15547-y · DOI · Paper page
  12. Cruzado, 2014, Longitudinal study of cognitive dysfunctions induced by adjuvant chemotherapy in colon cancer patients, Support. Care Cancer, 22, 1815
  13. Visovatti, 2016, Assessment of Cognitive Impairment and Complaints in Individuals with Colorectal Cancer, Oncol. Nurs. Forum, 43, 169, 10.1188/16.ONF.43-02AP · DOI
  14. Gao, Y., Xi, B., Zhang, Y., Mei, M., Zhai, M., Ling, Y., and Chu, W. (2025). Gut-brain axis and exosome-mediated communication in postoperative cognitive dysfunction associated with colorectal cancer. Acta Biochim. Biophys. Sin. · DOI
  15. Bourassa, 2017, Body mass and cognitive decline are indirectly associated via inflammation among aging adults, Brain Behav. Immun., 60, 63, 10.1016/j.bbi.2016.09.023 · DOI · Paper page
  16. Patra, D., Banerjee, D., Ramprasad, P., Roy, S., Pal, D., and Dasgupta, S. (2023). Recent insights of obesity-induced gut and adipose tissue dysbiosis in type 2 diabetes. Front. Mol. Biosci., 10. · DOI
  17. Patel, 2025, Gut Microbiota and its Impact on Chronic Diseases: A Comprehensive Review, J. Pharm. Bioallied Sci., 17, S1080, 10.4103/jpbs.jpbs_309_25 · DOI
  18. Virtue, 2019, The gut microbiota regulates white adipose tissue inflammation and obesity via a family of microRNAs, Sci. Transl. Med., 11, eaav1892, 10.1126/scitranslmed.aav1892 · DOI · Paper page
  19. Stavropoulou, E., Kantartzi, K., Tsigalou, C., Konstantinidis, T., Romanidou, G., Voidarou, C., and Bezirtzoglou, E. (2020). Focus on the Gut-Kidney Axis in Health and Disease. Front. Med., 7. · DOI
  20. Jia, X., Xu, W., Zhang, L., Li, X., Wang, R., and Wu, S. (2021). Impact of Gut Microbiota and Microbiota-Related Metabolites on Hyperlipidemia. Front. Cell. Infect. Microbiol., 11. · DOI
  21. Mishra, 2023, A mechanism by which gut microbiota elevates permeability and inflammation in obese/diabetic mice and human gut, Gut, 72, 1848, 10.1136/gutjnl-2022-327365 · DOI · Paper page
  22. Wang, Y., Wang, Z., Wang, Y., Li, F., Jia, J., Song, X., Qin, S., Wang, R., Jin, F., and Kitazato, K. (2018). The Gut-Microglia Connection: Implications for Central Nervous System Diseases. Front. Immunol., 9. · DOI
  23. Braniste, 2014, The gut microbiota influences blood-brain barrier permeability in mice, Sci. Transl. Med., 6, 263ra158, 10.1126/scitranslmed.3009759 · DOI · Paper page
  24. Ottria, R., Mirmajidi, S., and Ciuffreda, P. (2026). Gut Microbiota-Derived Short-Chain Fatty Acids in Inflammatory Bowel Disease: Mechanistic Insights into Gut Inflammation, Barrier Function, and Therapeutic Potential. Int. J. Mol. Sci., 27. · DOI
  25. Colombo, 2021, Microbiota-derived short chain fatty acids modulate microglia and promote Abeta plaque deposition, eLife, 10, e59826, 10.7554/eLife.59826 · DOI · Paper page
  26. Zhu, 2024, Multi-kingdom microbial signatures in excess body weight colorectal cancer based on global metagenomic analysis, Commun. Biol., 7, 24, 10.1038/s42003-023-05714-0 · DOI
  27. Garcia, 2019, Early-life obesity and adulthood colorectal cancer risk: A meta-analysis, Rev. Panam. Salud Publica, 43, e3, 10.26633/RPSP.2019.3 · DOI
  28. Chen, 2015, Association between adult weight gain and colorectal cancer: A dose-response meta-analysis of observational studies, Int. J. Cancer, 136, 2880, 10.1002/ijc.29331 · DOI
  29. Yu, 2017, Fusobacterium nucleatum Promotes Chemoresistance to Colorectal Cancer by Modulating Autophagy, Cell, 170, 548, 10.1016/j.cell.2017.07.008 · DOI · Paper page
  30. Turbitt, W.J., Collins, S.D., Meng, H., and Rogers, C.J. (2019). Increased Adiposity Enhances the Accumulation of MDSCs in the Tumor Microenvironment and Adipose Tissue of Pancreatic Tumor-Bearing Mice and in Immune Organs of Tumor-Free Hosts. Nutrients, 11. · DOI
  31. Fletcher, 2018, Colorectal cancer prevention: Immune modulation taking the stage, Biochim. Biophys. Acta Rev. Cancer, 1869, 138, 10.1016/j.bbcan.2017.12.002 · DOI
  32. Li, X., Larsson, P., Ljuslinder, I., Ohlund, D., Myte, R., Lofgren-Burstrom, A., Zingmark, C., Ling, A., Edin, S., and Palmqvist, R. (2020). Ex Vivo Organoid Cultures Reveal the Importance of the Tumor Microenvironment for Maintenance of Colorectal Cancer Stem Cells. Cancers, 12. · DOI
  33. Guinney, 2015, The consensus molecular subtypes of colorectal cancer, Nat. Med., 21, 1350, 10.1038/nm.3967 · DOI · Paper page
  34. McCorry, 2018, Epithelial-to-mesenchymal transition signature assessment in colorectal cancer quantifies tumour stromal content rather than true transition, J. Pathol., 246, 422, 10.1002/path.5155 · DOI
  35. Xu, 2017, Mature adipocytes observed to undergo reproliferation and polyploidy, FEBS Open Bio, 7, 652, 10.1002/2211-5463.12207 · DOI
  36. Xu, 2016, Preventive obesity agent montmorillonite adsorbs dietary lipids and enhances lipid excretion from the digestive tract, Sci. Rep., 6, 19659, 10.1038/srep19659 · DOI
  37. Xu, P., Zhai, Y., and Wang, J. (2018). The Role of PPAR and Its Cross-Talk with CAR and LXR in Obesity and Atherosclerosis. Int. J. Mol. Sci., 19. · DOI
  38. Wen, 2017, Adipocytes activate mitochondrial fatty acid oxidation and autophagy to promote tumor growth in colon cancer, Cell Death Dis., 8, e2593, 10.1038/cddis.2017.21 · DOI
  39. Puschhof, 2020, Mutational signature in colorectal cancer caused by genotoxic pks(+) E. coli, Nature, 580, 269, 10.1038/s41586-020-2080-8 · DOI · Paper page
  40. Zhu, 2007, PTP1B contributes to the oncogenic properties of colon cancer cells through Src activation, Cancer Res., 67, 10129, 10.1158/0008-5472.CAN-06-4338 · DOI · Paper page
  41. Nam, 2002, Src family kinase inhibitor PP2 restores the E-cadherin/catenin cell adhesion system in human cancer cells and reduces cancer metastasis, Clin. Cancer Res., 8, 2430
  42. Abbruzzese, 2015, Detection of phosphorylated insulin receptor in colorectal adenoma and adenocarcinoma: Implications for prognosis and clinical outcome, J. Cell. Physiol., 230, 562, 10.1002/jcp.24733 · DOI
  43. Kang, B., Zhang, X., Wang, W., She, S., Chen, W., Chen, C., Wang, Y., Pan, X., Xu, O., and Wang, Y. (2022). The Novel IGF-1R Inhibitor PB-020 Acts Synergistically with Anti-PD-1 and Mebendazole against Colorectal Cancer. Cancers, 14. · DOI
  44. Endo, 2011, Leptin acts as a growth factor for colorectal tumours at stages subsequent to tumour initiation in murine colon carcinogenesis, Gut, 60, 1363, 10.1136/gut.2010.235754 · DOI
  45. Aleksandrova, 2012, Leptin and soluble leptin receptor in risk of colorectal cancer in the European Prospective Investigation into Cancer and Nutrition cohort, Cancer Res., 72, 5328, 10.1158/0008-5472.CAN-12-0465 · DOI
  46. Jaffe, 2008, Leptin promotes motility and invasiveness in human colon cancer cells by activating multiple signal-transduction pathways, Int. J. Cancer, 123, 2543, 10.1002/ijc.23821 · DOI
  47. Yehuda-Shnaidman, E., Nimri, L., Tarnovscki, T., Kirshtein, B., Rudich, A., and Schwartz, B. (2013). Secreted human adipose leptin decreases mitochondrial respiration in HCT116 colon cancer cells. PLoS ONE, 8. · DOI
  48. Hardwick, 2001, Leptin is a growth factor for colonic epithelial cells, Gastroenterology, 121, 79, 10.1053/gast.2001.25490 · DOI
  49. Yoon, 2014, Leptin-induced adhesion and invasion in colorectal cancer cell lines, Oncol. Rep., 31, 2493, 10.3892/or.2014.3128 · DOI
  50. Aparicio, 2005, Leptin stimulates the proliferation of human colon cancer cells in vitro but does not promote the growth of colon cancer xenografts in nude mice or intestinal tumorigenesis in Apc(Min/+) mice, Gut, 54, 1136, 10.1136/gut.2004.060533 · DOI
  51. Sugiyama, 2009, Adiponectin inhibits colorectal cancer cell growth through the AMPK/mTOR pathway, Int. J. Oncol., 34, 339
  52. Moon, 2013, Salutary effects of adiponectin on colon cancer: In vivo and in vitro studies in mice, Gut, 62, 561, 10.1136/gutjnl-2012-302092 · DOI
  53. Murphy, 2020, Circulating Levels of Insulin-like Growth Factor 1 and Insulin-like Growth Factor Binding Protein 3 Associate with Risk of Colorectal Cancer Based on Serologic and Mendelian Randomization Analyses, Gastroenterology, 158, 1300, 10.1053/j.gastro.2019.12.020 · DOI
  54. Ley, 2005, Obesity alters gut microbial ecology, Proc. Natl. Acad. Sci. USA, 102, 11070, 10.1073/pnas.0504978102 · DOI · Paper page
  55. Magne, F., Gotteland, M., Gauthier, L., Zazueta, A., Pesoa, S., Navarrete, P., and Balamurugan, R. (2020). The Firmicutes/Bacteroidetes Ratio: A Relevant Marker of Gut Dysbiosis in Obese Patients?. Nutrients, 12. · DOI · Paper page
  56. Peng, 2009, Butyrate enhances the intestinal barrier by facilitating tight junction assembly via activation of AMP-activated protein kinase in Caco-2 cell monolayers, J. Nutr., 139, 1619, 10.3945/jn.109.104638 · DOI · Paper page
  57. Everard, 2013, Cross-talk between Akkermansia muciniphila and intestinal epithelium controls diet-induced obesity, Proc. Natl. Acad. Sci. USA, 110, 9066, 10.1073/pnas.1219451110 · DOI · Paper page
  58. Chelakkot, 2018, Akkermansia muciniphila-derived extracellular vesicles influence gut permeability through the regulation of tight junctions, Exp. Mol. Med., 50, e450, 10.1038/emm.2017.282 · DOI
  59. Wu, 2009, A human colonic commensal promotes colon tumorigenesis via activation of T helper type 17 T cell responses, Nat. Med., 15, 1016, 10.1038/nm.2015 · DOI · Paper page
  60. Guzik, 2017, The role of infiltrating immune cells in dysfunctional adipose tissue, Cardiovasc. Res., 113, 1009, 10.1093/cvr/cvx108 · DOI · Paper page
  61. Madka, 2023, Targeting IL-23 for the interception of obesity-associated colorectal cancer, Neoplasia, 45, 100939, 10.1016/j.neo.2023.100939 · DOI
  62. Ha, 2020, Translocation of Viable Gut Microbiota to Mesenteric Adipose Drives Formation of Creeping Fat in Humans, Cell, 183, 666, 10.1016/j.cell.2020.09.009 · DOI
  63. Massier, 2020, Adipose tissue derived bacteria are associated with inflammation in obesity and type 2 diabetes, Gut, 69, 1796, 10.1136/gutjnl-2019-320118 · DOI · Paper page
  64. Andreis, 2013, Lack of a chemobrain effect for adjuvant FOLFOX chemotherapy in colon cancer patients. A pilot study, Support. Care Cancer, 21, 583
  65. Banks, 2015, Lipopolysaccharide-induced blood-brain barrier disruption: Roles of cyclooxygenase, oxidative stress, neuroinflammation, and elements of the neurovascular unit, J. Neuroinflamm., 12, 223, 10.1186/s12974-015-0434-1 · DOI · Paper page
  66. Sampson, 2015, Control of brain development, function, and behavior by the microbiome, Cell Host Microbe, 17, 565, 10.1016/j.chom.2015.04.011 · DOI · Paper page
  67. Sumi, 2010, Lipopolysaccharide-activated microglia induce dysfunction of the blood-brain barrier in rat microvascular endothelial cells co-cultured with microglia, Cell. Mol. Neurobiol., 30, 247, 10.1007/s10571-009-9446-7 · DOI · Paper page
  68. Habbas, 2015, Neuroinflammatory TNFalpha Impairs Memory via Astrocyte Signaling, Cell, 163, 1730, 10.1016/j.cell.2015.11.023 · DOI · Paper page
  69. Chenghan, 2025, Short-chain fatty acids mediate gut microbiota-brain communication and protect the blood-brain barrier integrity, Ann. N. Y. Acad. Sci., 1545, 116, 10.1111/nyas.15299 · DOI
  70. Zhang, 2012, Altered spontaneous activity in Alzheimer’s disease and mild cognitive impairment revealed by Regional Homogeneity, Neuroimage, 59, 1429, 10.1016/j.neuroimage.2011.08.049 · DOI · Paper page
  71. Jiang, 2016, Regional Homogeneity: A Multimodal, Multiscale Neuroimaging Marker of the Human Connectome, Neuroscientist, 22, 486, 10.1177/1073858415595004 · DOI
  72. Pelosof, 2010, Paraneoplastic syndromes: An approach to diagnosis and treatment, Mayo Clin. Proc., 85, 838, 10.4065/mcp.2010.0099 · DOI · Paper page
  73. Lee, 2022, Atypical Cognitive Impairment and Recovery in Two Colorectal Cancer Patients, Tomography, 8, 1503, 10.3390/tomography8030123 · DOI
  74. Allen, 2018, Exercise Alters Gut Microbiota Composition and Function in Lean and Obese Humans, Med. Sci. Sports Exerc., 50, 747, 10.1249/MSS.0000000000001495 · DOI · Paper page
  75. Lourenco, 2019, Exercise-linked FNDC5/irisin rescues synaptic plasticity and memory defects in Alzheimer’s models, Nat. Med., 25, 165, 10.1038/s41591-018-0275-4 · DOI · Paper page
  76. Guo, 2019, Roux-en-Y gastric bypass decreases endotoxemia and inflammatory stress in association with improvements in gut permeability in obese diabetic rats, J. Diabetes, 11, 786, 10.1111/1753-0407.12906 · DOI
  77. Depommier, 2019, Supplementation with Akkermansia muciniphila in overweight and obese human volunteers: A proof-of-concept exploratory study, Nat. Med., 25, 1096, 10.1038/s41591-019-0495-2 · DOI · Paper page
  78. Mount, S., Canfora, E.E., Jocken, J.W., Umanets, A., Hul, G., Coenjaerds, M., Aldaz Laquidain, P., Adriaens, M.E., Holst, J.J., and Jardon, K.M. (2026). Pasteurized Akkermansia muciniphila MucT for weight loss maintenance in people with overweight and obesity: A controlled randomized trial. Nat. Med., 13. · DOI
  79. Zhang, 2025, Akkermansia muciniphila supplementation in patients with overweight/obese type 2 diabetes: Efficacy depends on its baseline levels in the gut, Cell Metab., 37, 592, 10.1016/j.cmet.2024.12.010 · DOI
  80. Wu, 2026, The Effects of a Prebiotic Formula Promoting Akkermansia muciniphila (AKK) on Gut Health: A Single-Centre, Randomised Controlled Trial, Int. J. Med. Sci., 23, 1952, 10.7150/ijms.125881 · DOI
  81. Vendrik, K.E.W., Ooijevaar, R.E., de Jong, P.R.C., Laman, J.D., van Oosten, B.W., van Hilten, J.J., Ducarmon, Q.R., Keller, J.J., Kuijper, E.J., and Contarino, M.F. (2020). Fecal Microbiota Transplantation in Neurological Disorders. Front. Cell. Infect. Microbiol., 10. · DOI · Paper page
  82. Leffler, 2015, Larazotide acetate for persistent symptoms of celiac disease despite a gluten-free diet: A randomized controlled trial, Gastroenterology, 148, 1311, 10.1053/j.gastro.2015.02.008 · DOI
  83. Li, 2025, Prebiotics chronotherapy alleviates depression-like behaviors in FMT mice through enhancing short-chain fatty acids receptors and intestinal barrier, J. Affect. Disord., 391, 119885, 10.1016/j.jad.2025.119885 · DOI
  84. Liu, 2024, Oxymatrine and Gut Microbiota Modulation: A Potential Therapeutic Strategy for Bone Cancer Pain Management, J. Pain, 25, 104588, 10.1016/j.jpain.2024.104588 · DOI
  85. Veerareddy, V., Wang, Z., Kashyap, P.C., and Kandimalla, K.K. (2025). Butyrate regulates the blood-brain barrier transport and intra-endothelial accumulation of Alzheimer’s disease Amyloid-beta peptides. bioRxiv. · DOI
  86. Li, 2024, Adaptive Metabolic Responses Facilitate Blood-Brain Barrier Repair in Ischemic Stroke via BHB-Mediated Epigenetic Modification of ZO-1 Expression, Adv. Sci., 11, e2400426, 10.1002/advs.202400426 · DOI
  87. Pervaiz, 2023, Ketone bodies supplementation restores the barrier function, induces a metabolic switch, and elicits beta-hydroxybutyrate diffusion across a monolayer of iPSC-derived brain microvascular endothelial cells, Microvasc. Res., 150, 104585, 10.1016/j.mvr.2023.104585 · DOI
  88. Chen, M., Zhang, J., Yang, H., Lei, L., Yang, L., Wang, S., and Yu, H. (2026). JK5G postbiotics modulate gut microbiota and metabolome to alleviate cancer-related pain: A randomized controlled trial with multi-omics integration. Front. Immunol., 17. · DOI

Metadata

Authors
Lee, S. Y., Cho, S. H., & Song, J.
Venue
Nutrients
Publisher
MDPI AG
Published
2026-06-12
Volume
18
Issue
12
Pages
1909
ISSN
2072-6643
Cited by
0
References
6
Language
en
Funders
  • National Research Foundation of Korea (RS-2025-02213506, RS-2025-19612989)
  • Korea Health Industry Development Institute (RS-2025-19252970)
  • Chonnam National University Hwasun Hospital Institute for Biomedical Science (HCRI26026)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: From Leaky Gut to a Vulnerable Brain: Obesity-Associated Gut Barrier Failure in Colorectal Cancer and Cognitive Dysfunction. https://app.cochat.ai/papers/10.3390/nu18121909
The paper
Lee, S. Y., Cho, S. H., & Song, J. (2026). From Leaky Gut to a Vulnerable Brain: Obesity-Associated Gut Barrier Failure in Colorectal Cancer and Cognitive Dysfunction. Nutrients. https://doi.org/10.3390/nu18121909

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.